Search research articles
Contact Us
Filters
Showing results (121-130 of 420) with videos related to
Page
of 42
Sort By:
British Medical Journal
|
January 18, 1975
Letter: The disc sensitivity test
J Sherris, C Thornsberry, A L Barry
American Journal of Clinical Pathology
|
August 1, 1983
Cefuroxime, cefamandole, cefoxitin, and cephalothin in vitro susceptibility tests: reassessment of the "class representative" concept, confirmation of disk interpretive criteria, and proposed quality control guidelines
A L Barry, R N Jones, C Thornsberry
Diagnostic Microbiology and Infectious Disease
|
December 1, 1983
Ceftriaxone: a summary of in vitro antibacterial qualities including recommendations for susceptibility tests with 30-micrograms disks
R N Jones, A L Barry, C Thornsberry
European Journal of Clinical Microbiology
|
April 1, 1985
Interpretive standards of cefbuperazone disk diffusion susceptibility tests
A L Barry, R N Jones, C Thornsberry
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
June 1, 1989
Quality control parameters and interpretive criteria for in vitro susceptibility tests with the macrolide azithromycin. Collaborative Antimicrobial Susceptibility Testing Group
A L Barry, C Thornsberry, T L Gavan
European Journal of Clinical Microbiology
|
February 1, 1987
Disk diffusion and disk elution tests with A-56268 and erythromycin
A L Barry, R N Jones, C Thornsberry
Journal of Clinical Microbiology
|
May 1, 1981
Gentamicin and amikacin disk susceptibility tests with Pseudomonas aeruginosa: definition of minimal inhibitory concentration correlates for susceptible and resistant categories
A L Barry, C Thornsberry, R N Jones
Antimicrobial Agents and Chemotherapy
|
August 1, 1983
In vitro evaluation of three new macrolide antimicrobial agents, RU28965, RU29065, and RU29702, and comparisons with other orally administered drugs
R N Jones, A L Barry, C Thornsberry
Diagnostic Microbiology and Infectious Disease
|
April 1, 1986
Cefpirome (HR810) disk diffusion susceptibility tests: confirmation of interpretive criteria using cefotaxime and cefoperazone-resistant strains and effects of blood supplemented media
R N Jones, A L Barry, C Thornsberry
Journal of Clinical Microbiology
|
February 1, 1984
Interpretive standards and quality control limits for susceptibility tests with ampicillin-sulbactam combination disks
A L Barry, R N Jones, C Thornsberry
Page
of 42
Search research articles
Search
Showing results (121-130 of 420) with videos related to
Sort By:
Page
of 42
British Medical Journal
|
January 18, 1975
Letter: The disc sensitivity test
J Sherris, C Thornsberry, A L Barry
American Journal of Clinical Pathology
|
August 1, 1983
Cefuroxime, cefamandole, cefoxitin, and cephalothin in vitro susceptibility tests: reassessment of the "class representative" concept, confirmation of disk interpretive criteria, and proposed quality control guidelines
A L Barry, R N Jones, C Thornsberry
Diagnostic Microbiology and Infectious Disease
|
December 1, 1983
Ceftriaxone: a summary of in vitro antibacterial qualities including recommendations for susceptibility tests with 30-micrograms disks
R N Jones, A L Barry, C Thornsberry
European Journal of Clinical Microbiology
|
April 1, 1985
Interpretive standards of cefbuperazone disk diffusion susceptibility tests
A L Barry, R N Jones, C Thornsberry
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
June 1, 1989
Quality control parameters and interpretive criteria for in vitro susceptibility tests with the macrolide azithromycin. Collaborative Antimicrobial Susceptibility Testing Group
A L Barry, C Thornsberry, T L Gavan
European Journal of Clinical Microbiology
|
February 1, 1987
Disk diffusion and disk elution tests with A-56268 and erythromycin
A L Barry, R N Jones, C Thornsberry
Journal of Clinical Microbiology
|
May 1, 1981
Gentamicin and amikacin disk susceptibility tests with Pseudomonas aeruginosa: definition of minimal inhibitory concentration correlates for susceptible and resistant categories
A L Barry, C Thornsberry, R N Jones
Antimicrobial Agents and Chemotherapy
|
August 1, 1983
In vitro evaluation of three new macrolide antimicrobial agents, RU28965, RU29065, and RU29702, and comparisons with other orally administered drugs
R N Jones, A L Barry, C Thornsberry
Diagnostic Microbiology and Infectious Disease
|
April 1, 1986
Cefpirome (HR810) disk diffusion susceptibility tests: confirmation of interpretive criteria using cefotaxime and cefoperazone-resistant strains and effects of blood supplemented media
R N Jones, A L Barry, C Thornsberry
Journal of Clinical Microbiology
|
February 1, 1984
Interpretive standards and quality control limits for susceptibility tests with ampicillin-sulbactam combination disks
A L Barry, R N Jones, C Thornsberry
Page
of 42